HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Karin Jirström Selected Research

Gemcitabine

2/2022Pre-clinical and clinical studies on the role of RBM3 in muscle-invasive bladder cancer: longitudinal expression, transcriptome-level effects and modulation of chemosensitivity.
1/2016Prognostic effect of hENT1, dCK and HuR expression by morphological type in periampullary adenocarcinoma, including pancreatic cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Karin Jirström Research Topics

Disease

170Neoplasms (Cancer)
04/2024 - 02/2005
96Breast Neoplasms (Breast Cancer)
03/2024 - 01/2005
41Adenocarcinoma
04/2024 - 02/2011
27Colorectal Neoplasms (Colorectal Cancer)
01/2023 - 11/2009
16Ovarian Neoplasms (Ovarian Cancer)
04/2024 - 06/2010
15Neoplasm Metastasis (Metastasis)
03/2021 - 01/2007
14Melanoma (Melanoma, Malignant)
01/2020 - 07/2011
11Pancreatic Neoplasms (Pancreatic Cancer)
04/2023 - 10/2014
10Lymphatic Metastasis
04/2024 - 09/2009
10Carcinoma (Carcinomatosis)
02/2022 - 01/2007
9Urinary Bladder Neoplasms (Bladder Cancer)
02/2022 - 04/2013
9Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020 - 11/2012
8Noninfiltrating Intraductal Carcinoma (DCIS)
06/2020 - 11/2010
8Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2020 - 07/2013
7Lung Neoplasms (Lung Cancer)
01/2020 - 04/2010
7Ovarian Epithelial Carcinoma
01/2018 - 08/2010
6Microsatellite Instability
01/2022 - 08/2012
6Carcinogenesis
01/2021 - 03/2010
6Disease Progression
07/2015 - 05/2010
6Prostatic Neoplasms (Prostate Cancer)
01/2015 - 01/2007
5Stomach Neoplasms (Stomach Cancer)
03/2021 - 12/2014
4Inflammation (Inflammations)
08/2022 - 01/2015
4Obesity
01/2019 - 09/2008
3Fibrosis (Cirrhosis)
04/2024 - 01/2022
3Colonic Neoplasms (Colon Cancer)
06/2023 - 11/2013
3Hypoxia (Hypoxemia)
01/2020 - 05/2006
3Adenocarcinoma of Lung
01/2020 - 11/2014
2Tertiary Lymphoid Structures
01/2020 - 01/2020
2Body Weight (Weight, Body)
01/2019 - 11/2013

Drug/Important Bio-Agent (IBA)

81Proteins (Proteins, Gene)FDA Link
03/2024 - 02/2005
50Biomarkers (Surrogate Marker)IBA
11/2023 - 04/2007
29Estrogen ReceptorsIBA
01/2022 - 07/2005
24TamoxifenFDA LinkGeneric
11/2021 - 01/2005
23Messenger RNA (mRNA)IBA
02/2022 - 11/2006
16Hormones (Hormone)IBA
11/2020 - 07/2005
12Cyclin D1IBA
08/2017 - 09/2005
11Progesterone Receptors (Progesterone Receptor)IBA
01/2020 - 07/2005
10AntibodiesIBA
01/2018 - 10/2008
9RNA (Ribonucleic Acid)IBA
02/2023 - 11/2006
9Estrogens (Estrogen)FDA Link
01/2018 - 05/2007
8ErbB Receptors (EGF Receptor)IBA
01/2020 - 07/2007
8podocalyxinIBA
01/2020 - 07/2012
7Small Interfering RNA (siRNA)IBA
02/2022 - 11/2008
7DNA (Deoxyribonucleic Acid)IBA
10/2015 - 04/2007
6Phenobarbital (Luminal)FDA Link
08/2022 - 10/2008
6Estrogen Receptor alphaIBA
01/2021 - 05/2006
6Oxidoreductases (Dehydrogenase)IBA
01/2018 - 01/2008
6Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2018 - 09/2008
6Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA
01/2015 - 01/2008
5LigandsIBA
11/2023 - 11/2013
5Complement Inactivating AgentsIBA
05/2023 - 04/2015
5ParaffinIBA
01/2022 - 07/2011
5Epidermal Growth Factor (EGF)IBA
03/2021 - 01/2016
5beta CateninIBA
02/2021 - 08/2012
5Carrier Proteins (Binding Protein)IBA
01/2021 - 07/2011
5Thyroid Nuclear Factor 1IBA
01/2019 - 07/2013
4Cartilage Oligomeric Matrix ProteinIBA
04/2024 - 01/2022
4human ERBB2 proteinIBA
08/2020 - 07/2005
4Keratin-5 (Keratin 5)IBA
01/2019 - 11/2010
4Protein Isoforms (Isoforms)IBA
02/2017 - 04/2010
4Glycoproteins (Glycoprotein)IBA
01/2016 - 07/2012
4CytokinesIBA
10/2015 - 09/2011
4Tumor Biomarkers (Tumor Markers)IBA
01/2013 - 08/2011
3CollagenIBA
04/2024 - 01/2022
3AntioxidantsIBA
12/2023 - 07/2014
3Cisplatin (Platino)FDA LinkGeneric
02/2022 - 08/2010
3Formaldehyde (Formol)FDA Link
01/2022 - 08/2016
3Trastuzumab (Herceptin)FDA Link
01/2020 - 04/2010
3AntigensIBA
01/2020 - 01/2009
3Transcription Factors (Transcription Factor)IBA
01/2020 - 01/2010
3Oral ContraceptivesIBA
01/2018 - 05/2014
3CoffeeFDA Link
01/2018 - 07/2014
3ChemokinesIBA
10/2016 - 09/2011
3ezrinIBA
10/2014 - 01/2007
3Polymeric Immunoglobulin Receptors (Polymeric Immunoglobulin Receptor)IBA
04/2014 - 01/2014
3RNA-Binding Proteins (RNA-Binding Protein)IBA
09/2011 - 12/2009
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2008 - 02/2005
3Cyclin EIBA
04/2007 - 11/2005
2CateninsIBA
04/2024 - 04/2014
2Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
12/2023 - 01/2021
2rho-Associated KinasesIBA
06/2023 - 11/2013
2Insulin (Novolin)FDA Link
08/2022 - 01/2017
2Caveolin 1IBA
08/2022 - 01/2020
2GemcitabineFDA Link
02/2022 - 01/2016
2Insulin-Like Growth Factor Binding ProteinsIBA
11/2021 - 01/2021
2Junctional Adhesion Molecule AIBA
03/2021 - 02/2021
2IGF Type 1 Receptor (IGF 1 Receptor)IBA
01/2021 - 02/2017
2TubulinIBA
01/2021 - 05/2012
2CholesterolIBA
01/2021 - 04/2015
2Immunoglobulins (Immunoglobulin)IBA
01/2019 - 12/2016

Therapy/Procedure

34Therapeutics
03/2021 - 08/2006
17Drug Therapy (Chemotherapy)
11/2023 - 06/2011
11Radiotherapy
04/2024 - 08/2011
10Neoadjuvant Therapy
01/2022 - 08/2011
7Immunotherapy
02/2023 - 01/2020
7Adjuvant Chemotherapy
01/2022 - 09/2009
6Pancreaticoduodenectomy
01/2018 - 01/2014
5Hormone Replacement Therapy (Therapy, Hormone Replacement)
01/2018 - 05/2007
3Prostatectomy (Retropubic Prostatectomy)
04/2013 - 05/2010
2Cystectomy
02/2022 - 01/2019